OBrien J, Kadirvelraj R, Tseng P, Ross-Kemppinen N, Crich D, Walsh Jr R
Biochemistry. 2024; 64(1):92-104.
PMID: 39680853
PMC: 11713868.
DOI: 10.1021/acs.biochem.4c00555.
Liang R, Hsu S, Chang T, Chiang T, Wang H, Ueng Y
J Food Drug Anal. 2024; 30(3):331-356.
PMID: 39666289
PMC: 9635916.
DOI: 10.38212/2224-6614.3421.
Kwak Y, Stambler I, Hyun Yoo H, Yoon J
Front Vet Sci. 2024; 11:1425089.
PMID: 39403214
PMC: 11471734.
DOI: 10.3389/fvets.2024.1425089.
Kumaree K, Anthikapalli N, Prasansuklab A
F1000Res. 2024; 12:655.
PMID: 39132582
PMC: 11310656.
DOI: 10.12688/f1000research.134956.2.
Sun H, Luo M, Zhou M, Zheng L, Li H, Esworthy R
J Mol Cell Biol. 2024; 16(5).
PMID: 38714348
PMC: 11574390.
DOI: 10.1093/jmcb/mjae019.
Forward or Backward: Lessons Learned from Small Molecule Drugs Approved by FDA from 2012 to 2022.
Gu M, Sun S, You Q, Wang L
Molecules. 2023; 28(24).
PMID: 38138431
PMC: 10745639.
DOI: 10.3390/molecules28247941.
Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution.
Spreitzer I, Keife J, Strasser T, Kalaba P, Lubec J, Neuhaus W
Int J Mol Sci. 2023; 24(23).
PMID: 38069277
PMC: 10707468.
DOI: 10.3390/ijms242316956.
Integrated Network Pharmacology, Molecular Docking, Molecular Simulation, and In Vitro Validation Revealed the Bioactive Components in Soy-Fermented Food Products and the Underlying Mechanistic Pathways in Lung Cancer.
Elkhalifa A, Banu H, Khan M, Ashraf S
Nutrients. 2023; 15(18).
PMID: 37764733
PMC: 10537301.
DOI: 10.3390/nu15183949.
Molecular dynamics simulation analysis of alpha-cobra toxin docked with phytochemical compounds.
Alshammari A, Alrashidi M, Alshammari W, Aloufi B, Altamimi H
Bioinformation. 2023; 18(9):834-840.
PMID: 37426504
PMC: 10326343.
DOI: 10.6026/97320630018834.
Understanding the Structure-Activity Relationship through Density Functional Theory: A Simple Method Predicts Relative Binding Free Energies of Metalloenzyme Fragment-like Inhibitors.
Vasile S, Roos K
ACS Omega. 2023; 8(24):21438-21449.
PMID: 37360476
PMC: 10285960.
DOI: 10.1021/acsomega.2c08156.
Recent Advances on the Biological Study of Pharmaceutical Cocrystals.
Wang Z, Xie Y, Yu M, Yang S, Lu Y, Du G
AAPS PharmSciTech. 2022; 23(8):303.
PMID: 36396736
DOI: 10.1208/s12249-022-02451-1.
Screening of drug candidates against Endothelin-1 to treat hypertension using computational based approaches: Molecular docking and dynamics simulation.
Fatima I, Ihsan H, Masoud M, Kalsoom S, Aslam S, Rehman A
PLoS One. 2022; 17(8):e0269739.
PMID: 35981003
PMC: 9387841.
DOI: 10.1371/journal.pone.0269739.
Pharmacokinetic/Pharmacodynamic Modeling and Application in Antibacterial and Antifungal Pharmacotherapy: A Narrative Review.
Pereira L, Fatima M, Santos V, Brandao C, Alves I, Azeredo F
Antibiotics (Basel). 2022; 11(8).
PMID: 35892376
PMC: 9330032.
DOI: 10.3390/antibiotics11080986.
Glioblastoma: Current Status, Emerging Targets, and Recent Advances.
Thakur A, Faujdar C, Sharma R, Sharma S, Malik B, Nepali K
J Med Chem. 2022; 65(13):8596-8685.
PMID: 35786935
PMC: 9297300.
DOI: 10.1021/acs.jmedchem.1c01946.
Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors.
Alamri M, Mirza M, Adeel M, Ashfaq U, Tahir Ul Qamar M, Shahid F
Pharmaceuticals (Basel). 2022; 15(6).
PMID: 35745579
PMC: 9228520.
DOI: 10.3390/ph15060659.
Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3Rs.
Yuan Y, He Q, Zhang S, Li M, Tang Z, Zhu X
Front Pharmacol. 2022; 13:895556.
PMID: 35645843
PMC: 9133488.
DOI: 10.3389/fphar.2022.895556.
Molecular Basis Underlying Hepatobiliary and Renal Excretion of Phenolic Acids of Roots (Danshen).
Lu J, Zeng X, Zhou X, Yang J, Ren L, Long X
Front Pharmacol. 2022; 13:911982.
PMID: 35620286
PMC: 9127186.
DOI: 10.3389/fphar.2022.911982.
Pharmacokinetic profile and metabolite identification of bornyl caffeate and caffeic acid in rats by high performance liquid chromatography coupled with mass spectrometry.
Shi B, Yang L, Gao T, Ma C, Li Q, Nan Y
RSC Adv. 2022; 9(7):4015-4027.
PMID: 35518073
PMC: 9060532.
DOI: 10.1039/c8ra07972b.
Engineering a protease-based and site-specific PEGylation-based strategy for the controlled release of exenatide.
Zhang A, Lin Y, Nong S, Zhao W, Dong M
RSC Adv. 2022; 10(42):25013-25021.
PMID: 35517470
PMC: 9055162.
DOI: 10.1039/d0ra01010c.
Exploring stereoselective excretion and metabolism studies of novel 2-(2-hydroxypropanamido)-5-trifluoromethyl benzoic acid enantiomers.
Rong R, Zhang Q, Zhang R, Dan Y, Wang X, Zhao Y
RSC Adv. 2022; 10(46):27267-27279.
PMID: 35516918
PMC: 9055496.
DOI: 10.1039/d0ra03500a.
